Matthew Lammi is a Respiratory physician. OpenAlex indexes 149 publications with 1,433 citations (h-index 24); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Baltimore, MD 212870005
Telephone
410-955-5000Provider last certified this registry record 27 Jun 2023.
Clinical trials
- Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary Hypertension
Sponsor: Louisiana State University Health Sciences Center in New Orleans
- Correlation Between Estimated Right Atrial Pressure and BNP in Pulmonary HTN (CRAB-PH)
Sponsor: Louisiana State University Health Sciences Center in New Orleans
- Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension
Sponsor: American Medical Association Foundation
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Digestive Care, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
33.6%Corticosteroid33.6%Prednisone100%Part D≥14 patientsCardiovascular
25.8%Endothelin Receptor Antagonist25.8%Opsumit100%Part D≥12 patientsGenitourinary & hormones
13.3%Phosphodiesterase 5 Inhibitor13.3%Tadalafil100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2025–2025 per NIH RePORTER. The latest:
- Unsupervised Machine Learning to Identify Unique Clusters of Systemic Sclerosis Pulmonary Hypertension Patients
Johns Hopkins University
FY2025$245,624R21HL172119
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Refining Risk Prediction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension
Journal of the American Society of Echocardiography
2025 - Investigating the “sex paradox” in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR)
The Journal of Heart and Lung Transplantation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”